Xi-ming Li

Dopamine D1 receptors are involved in the modulation of D2 receptors induced by cholecystokinin receptor subtypes in rat neostriatal membranes

K. Fuxe, L. Agnati, P. Hedlund, 1994, Brain Research.

Possible involvement of G-proteins in the regulation of striatal dopamine D2 receptor affinity by cholecystokinin octapeptide

K. Fuxe, A. Jansson, L. Agnati, 1997, Neuroscience Letters.

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum

D. Wong, K. Perry, F. Bymaster, 1998, Psychopharmacology.

A single (−)-nicotine injection causes change with a time delay in the affinity of striatal D2 receptors for antagonist, but not for agonist, nor in the D2 receptor mRNA levels in the rat substantia nigra

J. Changeux, K. Fuxe, M. Zoli, 1995, Brain Research.

Cholecystokinin octapeptide and the D2 antagonist raclopride induce Fos-like immunoreactivity in the shell part of the rat nucleus accumbens via different mechanisms

K. Fuxe, G. Chadi, Xi-ming Li, 1995, Brain Research.

On the In‐vivo Modulation of Neostriatal Dopamine Release by Fluoxetine and 5−Hydroxy‐L‐tryptophan in Conscious Rats

K. Perry, R. Fuller, X. M. Li, 1996, The Journal of pharmacy and pharmacology.

Neuromedin N is a potent modulator of dopamine D2 receptor agonist binding in rat neostriatal membranes

K. Fuxe, P. Hedlund, G. Euler, 1993, Neuroscience Letters.